| Literature DB >> 35283543 |
Melika Mosleh1, Saeed Roshani2, Mario Coccia3.
Abstract
One of the main problems in scientometrics is to explore the factors that affect the growth of citations in publications to identify best practices of research policy to increase the diffusion of scientific research and knowledge in science and society. The principal purpose of this study is to analyze how research funding affects the citation-based performance of scientific output in vital research fields of life science, which is a critical province (area of knowledge) in science to improve the wellbeing of people. This study uses data from the Scopus database in 2015 (to assess the impact on citations in 2021, after more than 5 years) concerning different disciplines of life science, given by "agricultural and biological sciences", "biochemistry, genetics, and molecular biology", "Immunology and microbiology", "neuroscience" and "pharmacology, toxicology and pharmaceutics". Results demonstrate that although journals publish un-funded articles more than funded publications in all disciplines of life science, the fraction of total citations in funded papers is higher than the share in the total number of publications. In short, funded documents receive more citations than un-funded papers in all research fields of life science under study. Findings also support that citations of total (funded + un-funded), funded, and un-funded published papers have a power-law distribution in all five research fields of life science. Original results here reveal a general property in scientific development: funded research has a higher scaling potential than un-funded publications. Critical implications of research policy, systematized in a decision-making matrix, suggest that R&D investments in "Neuroscience" can generate a positive impact of scientific results in science and society-in terms of citations-higher than other research fields in medicine. Overall, then, results here can explain some characteristics driving scientific change and help policymakers and scholars to allocate resources towards research fields that facilitate the development and diffusion of scientific research and knowledge in life science for positive societal impact.Entities:
Keywords: Decision-making matrix; Power-law distribution; Research funding; Research policy; Science diffusion; Scientific development
Year: 2022 PMID: 35283543 PMCID: PMC8897117 DOI: 10.1007/s11192-022-04300-1
Source DB: PubMed Journal: Scientometrics ISSN: 0138-9130 Impact factor: 3.801
Fig. 1Theoretical decision-making matrix for decision support of funding research policy in scientific fields
The number of documents and citations in research fields of life science according to funding status
| Research fields | Sources | Number of papers | % | Citations | % |
|---|---|---|---|---|---|
| Agricultural and biological sciences | Totala | 187,276 | 100 | 3,044,146 | 100 |
| Funded | 52,048 | 27.79 | 1,177,076 | 38.67 | |
| Un-funded | 135,228 | 72.21 | 1,867,070 | 61.33 | |
| Biochemistry, genetics and molecular biology | Totala | 282,182 | 100 | 6,308,179 | 100 |
| Funded | 101,875 | 36.10 | 3,084,843 | 48.90 | |
| Un-funded | 180,307 | 63.90 | 3,223,336 | 51.10 | |
| Immunology and microbiology | Totala | 65,734 | 100 | 1,477,313 | 100 |
| Funded | 21,847 | 33.24 | 683,797 | 46.29 | |
| Un-funded | 43,887 | 66.76 | 793,516 | 53.71 | |
| Neuroscience | Totala | 62,323 | 100 | 1,425,246 | 100 |
| Funded | 27,956 | 44.86 | 811,597 | 56.94 | |
| Un-funded | 34,367 | 55.14 | 613,649 | 43.06 | |
| Pharmacology, toxicology and pharmaceutics | Totala | 78,360 | 100 | 1,257,310 | 100 |
| Funded | 24,600 | 31.40 | 547,863 | 43.57 | |
| Un-funded | 53,760 | 68.60 | 709,447 | 56.43 |
aTotal: the combination of funded and un-funded publications
Results of fitting the power-law to the datasets
| Research fields | Funding | Xmin | KS | |
|---|---|---|---|---|
| Agricultural and biological sciences | Totala | 4.574 | 2.45*** | 0.052 |
| Funded | 4.009 | 2.68*** | 0.063 | |
| Un-funded | 2.880 | 2.59*** | 0.038 | |
| Biochemistry, genetics and molecular biology | Totala | 5.626 | 2.32*** | 0.043 |
| Funded | 6.435 | 2.41*** | 0.052 | |
| Un-funded | 3.341 | 2.43*** | 0.020 | |
| Immunology and microbiology | Totala | 5.655 | 2.51*** | 0.064 |
| Funded | 2.128 | 2.17*** | 0.079 | |
| Un-funded | 1.631 | 2.30*** | 0.056 | |
| Neuroscience | Totala | 8.595 | 3.12*** | 0.093 |
| Funded | 4.538 | 2.57*** | 0.071 | |
| Un-funded | 2.939 | 3.05*** | 0.075 | |
| Pharmacology, toxicology and pharmaceutics | Totala | 9.117 | 3.31*** | 0.070 |
| Funded | 1.974 | 2.29*** | 0.104 | |
| Un-funded | 2.159 | 2.81*** | 0.071 |
aThe combination of funded and un-funded publications
***Denotes significance when Power-Law p-value > 0.1
Results of comparing the power-law with alternative distributions
| Research fields | Funding | Power-law | Power-law + cut-off | |
|---|---|---|---|---|
| Agricultural and biological sciences | Totala | 0.29 | 0.01 | 0.99 |
| Funded | 0.60 | 0.001 | 0.99 | |
| Un-funded | 0.85 | 0.11 | 0.79 | |
| Biochemistry, genetics and molecular biology | Totala | 0.44 | 0.01 | 0.99 |
| Funded | 0.61 | − 1.28 | 0.10 | |
| Un-funded | 0.93 | − 0.18 | 0.82 | |
| Immunology and Microbiology | Totala | 0.47 | − 1.22 | 0.11 |
| Funded | 0.16 | − 1.71 | 0.01 | |
| Un-funded | 0.33 | − 1.17 | 0.10 | |
| Neuroscience | Totala | 0.13 | − 0.43 | 0.67 |
| Funded | 0.56 | − 0.90 | 0.30 | |
| Un-funded | 0.33 | − 1.07 | 0.16 | |
| Pharmacology, toxicology and pharmaceutics | Totala | 0.50 | − 1.03 | 0.16 |
| Funded | 0.01 | − 2.01 | 0.002 | |
| Un-funded | 0.85 | − 0.21 | 0.42 | |
aTotal: the combination of funded and un-funded publications
Values of the exponents for the power-law correlation
| Research fields | Funding | α | Δ | (SD) | ||
|---|---|---|---|---|---|---|
| Agricultural and biological sciences | Totala | 1.35*** | (0.01) | 0.74 | 1970 | |
| Funded | 1.30*** | 0.04 | (0.01) | 0.83 | 1376 | |
| Un-funded | 1.26*** | (0.01) | 0.67 | 1960 | ||
| Biochemistry, genetics and molecular biology | Totala | 1.26*** | (0.01) | 0.76 | 2006 | |
| Funded | 1.21*** | 0.04 | (0.01) | 0.81 | 1294 | |
| Un-funded | 1.17*** | (0.01) | 0.68 | 1994 | ||
| Immunology and Microbiology | Totala | 1.32*** | (0.02) | 0.79 | 534 | |
| Funded | 1.28*** | 0.08 | (0.02) | 0.85 | 424 | |
| Un-funded | 1.20*** | (0.03) | 0.73 | 533 | ||
| Neuroscience | Totala | 1.28*** | (0.03) | 0.74 | 578 | |
| Funded | 1.30*** | 0.16 | (0.02) | 0.88 | 478 | |
| Un-funded | 1.14*** | (0.03) | 0.63 | 571 | ||
| Pharmacology, Toxicology and Pharmaceutics | Totala | 1.27*** | (0.03) | 0.68 | 717 | |
| Funded | 1.28*** | 0.10 | (0.02) | 0.85 | 515 | |
| Un-funded | 1.18*** | (0.03) | 0.59 | 707 |
p-value < 0.001
aTotal = funded + un-funded; α is the scaling factor, Δ = Difference between α (funded)- α(un-funded), SD Standard Deviation, R2 is the coefficient of determination, N Number of cases
The intensity of Matthew effect power on the number of citations for funded and un-funded publications across research fields of life science
| Intensity of power-law scaling effects | Papers | Papers |
|---|---|---|
| High Matthew effect | ||
| | Agricultural and biological sciences | |
| Neuroscience | ||
| Medium Matthew effect | ||
| 1.18 < | Immunology and Microbiology | |
| Pharmacology, toxicology and pharmaceutics | ||
| Biochemistry, Genetics and Molecular biology | Agricultural and Biological Sciences | |
| Immunology and Microbiology | ||
| Low Matthew effect | ||
| | Biochemistry, genetics and molecular biology | |
| Neuroscience | ||
| Pharmacology, toxicology and pharmaceutics | ||
α is the exponent of power-law correlation. High exponent of scaling for citations suggests information about the strength of Matthew effect in research fields. High α indicates a stronger Matthew effect in citation-based performance, vice versa a low value of α
Matthew effect gap between funded and un-funded publications across all five disciplines in life science
| Matthew effect gap | Funding leads to | Funding leads to | Research Policy implication |
|---|---|---|---|
| Δ ≥ 0.13 | Neuroscience | ||
| 0.04 < Δ < 0.13 | Pharmacology, Toxicology and Pharmaceutics | Immunology and Microbiology | |
| Δ ≤ 0.04 | Agricultural and Biological Sciences | Biochemistry, Genetics and Molecular Biology |
α is the exponent of power-law correlation, higher exponent of scaling for citations indicates a more powerful Matthew effect; Funding with a High Matthew effect: α-funded ≥ 1.29, Funding with a Medium Matthew effect: 1.18 < α-funded < 1.29. The information of funding for high/medium Matthew effect is from Table 5. Δ = α (funded)- α (un-funded) = Matthew effect Gap; higher Δ indicates that funding can have a significant impact on citations compared to un-funded publications. To improve the life science citation-based performance, adequate funding in disciplines with the highest delta (Δ) can generate a great difference in the scientific performance of publications and play an effective role in creating a scaling growth in the number of citations. The thresholds of the first column are calculated using the 25th and 75th percentiles of the values of delta (Δ): 25th percentiles (lower) are 0.04; the 75th percentiles (higher) are 0.13
Fig. 2Decision-making matrix for funding policy of research fields in life science according to their location
Average citations of publications of scholars awarded with Nobel Prize in Chemistry and Medicine in 2019 and 2020
| 2019–2020 | Chemistry | Medicine | ||
|---|---|---|---|---|
| Funded | Un-funded | Funded | Un-funded | |
| Papers (number) | 530 | 287 | 1044 | 641 |
| Citations | 95,829 | 31,063 | 201,583 | 144,305 |
| Average citations | 180.81 | 108.23 | 193.09 | 225.12 |